Cellular and Immune Therapy for Treating HIV-1 Infection

AIDS Rev. 2021 Feb 24. doi: 10.24875/AIDSRev.20000110. Online ahead of print.ABSTRACTHIV-1 infection has caused a number of deaths worldwide and remains a global health concern. Combined antiretroviral therapy (cART) inhibits viral replication, prevents CD4+ T cell loss, and thus slows HIV disease progression. However, cART does not eradicate HIV-1. Infected individuals must remain on treatment for their entire lives and treatment interruption will result in viral rebound.PMID:33626034 | DOI:10.24875/AIDSRev.20000110

Source: AIDS Reviews - February 24, 2021 Category: Infectious Diseases Authors: Wei Li Qiqiang Zhou Lingbo Xia Ruixiang Zou Wei Zou Source Type: research